Pulmonary Alveolar Proteinosis: Understanding the Rare Lung Condition

Oct 11

6 min read

Updated: 2 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Quick Answer

Pulmonary alveolar proteinosis (PAP) is a rare lung disorder in which surfactant, a mix of proteins and fats, builds up in the air sacs because macrophages fail to clear it, blocking oxygen from entering the blood. [1] Symptoms include progressive shortness of breath and fatigue. [1] [3] There is no cure, but whole-lung lavage, flushing the air sacs with saline, restores breathing. [1]

What the research says

Inhaled GM-CSF after lung washing cut the need for repeat lavage. In a randomized trial of 18 people with moderate-to-severe autoimmune PAP, all had a baseline whole-lung lavage and were then assigned to inhaled sargramostim or no scheduled therapy for 30 months. Rescue lavage was needed by 7 of 9 controls (78%) but only 1 of 9 treated patients (11%), and the treated group had greater gains in oxygen levels and diffusing capacity, with no serious adverse events (PubMed: Campo et al., Eur Respir J, 2024) [2].
PAP is rare, mostly autoimmune, and more common in smokers. A Nature Reviews Disease Primers review reports a prevalence of at least 7 cases per million in large population studies, with autoimmune PAP accounting for more than 90% of cases. It states that whole-lung lavage effectively removes the excess surfactant (PubMed: Trapnell et al., Nat Rev Dis Primers, 2019) [3].
Lavage is first-line, inhaled GM-CSF is second-line, and survival is generally good. A clinical review describes whole-lung lavage as first-line therapy with inhaled GM-CSF as second-line (inhalation being better than injection), notes that spontaneous improvement can occur, and gives a 5-year actuarial survival rate of 95% (PubMed: Jouneau et al., Respirology, 2020) [4].

What Is Pulmonary Alveolar Proteinosis?

Pulmonary Alveolar Proteinosis (PAP) is a serious lung condition that interferes with the vital exchange of oxygen and carbon dioxide. In a healthy lung, the thin walls of the alveoli are coated with a layer of surfactants that help them stay open. Normally, cells called alveolar macrophages clean away excess surfactant to prevent clogging. However, in individuals with PAP, these macrophages do not function correctly, allowing the oily buildup of proteins and fats to block the air sacs. [1]

This rare disease affects between 3 and 40 people per million globally. It is classified into three distinct categories based on its underlying cause: autoimmune, secondary, and congenital. Autoimmune PAP is the most frequent form, accounting for approximately 90% of adult cases, where the immune system mistakenly attacks the very cells needed to keep the lungs clear. [1]

PAP type	Primary cause	Common patient demographic
Autoimmune	Immune system attacks lung-clearing cells	Adults aged 30–60; more common in males
Secondary	Exposure to toxins, chemicals, or other diseases	Adults with high occupational dust exposure
Congenital	Genetic mutations inherited from parents	Children under 10; can appear at any age

Watercolor illustration comparing a normal alveolus on the left, with clear, open air sacs wrapped in blood vessels, to a diseased alveolus on the right that is filled with a thick yellow-orange surfactant clog. – rinnit.com — Figure 1: Normal alveoli (left) compared with alveoli clogged by surfactant in PAP (right).

What are the symptoms of pulmonary alveolar proteinosis?

The most prevalent symptom of PAP is shortness of breath, medically known as dyspnea. While many patients first notice this difficulty during physical exertion, severe cases can result in breathing problems even while at rest. [1] As the condition progresses and blood oxygen levels drop, additional symptoms may emerge, signaling the need for medical intervention.

Common clinical signs include:

Respiratory distress: Persistent cough, which may produce blood or phlegm, and chest pain. [1]
Systemic effects: Chronic fatigue, unexplained weight loss, and recurring lung infections. [1]
Physical markers: Cyanosis, a bluish tint to the skin and fingernails, and clubbed fingers, where the tips of the fingers enlarge and the nails curve. [1]

What causes pulmonary alveolar proteinosis, and who is at risk?

The root cause of PAP lies in the failure of alveolar macrophages to receive the necessary signals to clean the air sacs. [1] In autoimmune cases, this is due to the body producing antibodies that neutralize the signals. [3] Secondary PAP is often triggered by the inhalation of harmful substances, such as silica or certain chemicals, which damage the macrophages directly. Smoking is a significant risk factor that can exacerbate the condition or increase the likelihood of developing secondary PAP. [1] [3]

Congenital PAP is a hereditary form caused by specific genetic mutations that alter how lung cells function from birth. While it is not possible to prevent the autoimmune or genetic forms of the disease, individuals can reduce their risk of secondary PAP by avoiding environmental toxins and using appropriate respiratory protection in high-risk workplaces. [1]

Infographic titled Understanding PAP: Causes and Risk Factors with three columns: autoimmune attacks, where anti-GM-CSF antibodies block surfactant clearance; genetic mutations in the GM-CSF receptor genes; and environmental toxins such as silica dust and cigarette smoke. A summary notes that surfactant builds up in the alveoli and impairs gas exchange. – rinnit.com — Figure 2: The three main routes to PAP — autoimmune, genetic, and environmental.

How is pulmonary alveolar proteinosis diagnosed and managed?

Healthcare providers diagnose PAP through a combination of physical examinations, imaging, and specialized lung tests. [1] CT scans and chest X-rays often reveal a characteristic "crazy-paving" pattern in the lungs, which suggests surfactant buildup. [4] Definitive diagnosis may require a bronchoscopy or a lung biopsy to examine the fluid or tissue within the air sacs. [1]

Although there is no current cure [1], management focuses on clearing the lungs and improving oxygenation:

Whole-lung lavage (WLL): The standard treatment, involving a multi-hour procedure where a lung is flushed with saline while the patient is under anesthesia. [1] [4]
GM-CSF therapy: Inhaled or injected medication designed to help macrophages function more effectively. [1]
Advanced options: For severe cases, plasmapheresis may be used to filter the blood, or a lung transplant may be considered if permanent damage has occurred. [1]

Illustration of a whole-lung lavage in an operating room. A clinician guides a bronchoscope into one lung while the patient is ventilated, with labels for the saline solution bag, bronchoscope, ventilator, and lavage fluid collection bottle, plus icons for oxygen therapy and GM-CSF therapy. – rinnit.com — Figure 3: The whole-lung lavage procedure, with oxygen and GM-CSF therapy as supporting treatments.

Conclusion and Next Steps

Pulmonary Alveolar Proteinosis is a complex disease with a variable prognosis. While some patients experience spontaneous remission, others require lifelong management to maintain their respiratory health. With modern treatments like whole-lung lavage and emerging genetic therapies, many individuals with PAP can lead active lives. If you are experiencing persistent shortness of breath, it is essential to consult a pulmonologist for a thorough evaluation and personalized care plan.

Frequently Asked Questions

1. What exactly is PAP?

PAP is a rare lung disease where air sacs fill with a protein-fat mixture, blocking oxygen from entering the blood. [1]

2. Is PAP the same as a lung infection?

No, though it can increase your risk of developing secondary lung infections due to the buildup in the air sacs. [1] [4]

3. What is "lung washing"?

Medically known as whole-lung lavage, it is a procedure where a doctor uses saline to flush out the surfactants clogging the lungs. [1]

4. Can children develop this condition?

Yes, the congenital form of PAP is most common in children under the age of 10. [1]

5. Is smoking a factor in PAP?

Yes, smoking and exposure to secondhand smoke are known risk factors that can worsen the condition.

6. Can PAP be fatal?

In severe, untreated cases, it can lead to life-threatening respiratory failure. [1]

7. Does PAP ever go away on its own?

In a small number of cases, the condition may clear up without specific medical treatment. [1] [4]

8. What is cyanosis?

Cyanosis is a bluish discoloration of the skin and fingernails, indicating low oxygen levels in the blood. [1]

9. How long does a lung lavage take?

The procedure typically takes between four and five hours to complete. [1]

10. Is there a genetic test for PAP?

Yes, genetic testing can identify the mutations responsible for the congenital form of the disease.

References

Cleveland Clinic. Pulmonary Alveolar Proteinosis. Cleveland Clinic. Last updated Feb. 22, 2023. https://my.clevelandclinic.org/health/diseases/17398-pulmonary-alveolar-proteinosis
Campo I, Carey BC, Paracchini E, et al. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients. Eur Respir J. 2024;63(1). doi:10.1183/13993003.01233-2023. PMID: 37973175.
Trapnell BC, Nakata K, Bonella F, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019;5(1):16. doi:10.1038/s41572-019-0066-3. PMID: 30846703.
Jouneau S, Ménard C, Lederlin M. Pulmonary alveolar proteinosis. Respirology. 2020;25(8):816-826. doi:10.1111/resp.13831. PMID: 32363736.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here.